v3.26.1
NOTE 11 - BUSINESS SEGMENT INFORMATION: Schedule of Segment Reporting Information, by Segment (Tables)
6 Months Ended
Jun. 30, 2026
March 31, 2024  
Schedule of Segment Reporting Information, by Segment

 

 

CONSOLIDATED

HEALTH SUPPLEMENTS

CORPORATE

 

 

BergaMet

Gummy USA

UBN

Adli Gummies

 

Revenue

3,677,956

1,797,102

872,330

-

1,008,524

-

Cost of Revenue

1,236,811

778,586

353,531

-

104,694

-

Long-lived Assets

526,647

19,154

4,766

502,727

-

-

Gain (Loss) Before Income Tax

(329,486)

(55,516)

(736,615)

(1,051)

595,833

(132,137)

Identifiable Assets

644,114

482,265

127,044

-

34,805

-

Depreciation and Amortization

348,093

1,786

346,307

-

-

-

March 31, 2023  
Schedule of Segment Reporting Information, by Segment

 

 

CONSOLIDATED

HEALTH SUPPLEMENTS

CORPORATE

BergaMet

Gummy USA

UBN

Revenue

4,511,997

3,751,247

760,750

-

-

Cost of Revenue

2,433,103

2,219,096

214,007

-

-

Long-lived Assets

1,140,342

186,978

450,637

502,727

-

Gain (Loss) Before Income Tax

(881,119)

53,408

(154,242)

(300)

(779,985)

Identifiable Assets

843,357

737,862

105,495

-

-

Depreciation and Amortization

152,192

1,963

150,229

-

-